|Bid||92.50 x 800|
|Ask||0.00 x 800|
|Day's Range||86.32 - 94.52|
|52 Week Range||78.95 - 116.49|
|Beta (3Y Monthly)||0.93|
|PE Ratio (TTM)||17.60|
|Earnings Date||Jul 22, 2019 - Jul 26, 2019|
|Forward Dividend & Yield||2.12 (2.36%)|
|1y Target Est||94.72|
climbed 7.4% to $91.50 Tuesday after the diagnostic testing company reported better-than-expected first-quarter earnings. "We're off to a good start in 2019, with solid volume growth from our expanded health plan access," said Steve Rusckowski, chairman, president and CEO. "As we anticipated, volume accelerated through the quarter, and we look forward to continued progress as a member of UnitedHealthcare's Preferred Lab Network beginning July 1.
Quest Diagnostics (DGX) currently concentrates on its core diagnostic information services business and tries to maintain discipline in capital deployment.
The Secaucus, New Jersey-based company said it had net income of $1.20 per share. Earnings, adjusted for one-time gains and costs, came to $1.40 per share. The results surpassed Wall Street expectations. ...
- First quarter revenues of $1.89 billion , up 0.4% from 2018 - First quarter reported diluted EPS of $1.20 , down 5.4% from 2018; and adjusted diluted EPS of $1.40 , down 7.9% from 2018 - Cash provided ...
Moody's Investors Service ("Moody's") has completed a periodic review of the ratings of Quest Diagnostics Incorporated and other ratings that are associated with the same analytical unit. The review was conducted through a portfolio review in which Moody's reassessed the appropriateness of the ratings in the context of the relevant principal methodology(ies), recent developments, and a comparison of the financial and operating profile to similarly rated peers. This publication does not announce a credit rating action and is not an indication of whether or not a credit rating action is likely in the near future.
Quest was among one of only fifteen companies in the Health Care Equipment and Services category to attain the designation. Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management.
Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Quest Diagnostics Incorporated (NYSE:DGX) as an investment opportunity by taking the expected future cash flows and discounting them t...
SECAUCUS, N.J., April 18, 2019 /PRNewswire/ -- Quest Diagnostics (DGX), the world's leading provider of diagnostic information services, today launched three new sexually transmitted disease (STD) laboratory test packages that individuals can purchase online for some of the most prevalent STDs in the United States. The new STD test packages are the first to be offered directly by Quest Diagnostics or any other major national laboratory to allow individuals to purchase tests at their discretion.
Quest Diagnostics (DGX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analysis of more than ten million workplace drug test results shows increases in marijuana positivity across nearly all employee testing categories Increases in post-accident positivity in the general ...
Quest Diagnostics Inc NYSE:DGXView full report here! Summary * Perception of the company's creditworthiness is negative * ETFs holding this stock are seeing positive inflows * Bearish sentiment is moderate and increasing * Economic output in this company's sector is expanding Bearish sentimentShort interest | NeutralShort interest is moderate for DGX with between 5 and 10% of shares outstanding currently on loan. This represents an increase in short interest as investors who seek to profit from falling equity prices added to their short positions on April 5. Money flowETF/Index ownership | PositiveETF activity is positive. Over the last month, growth of ETFs holding DGX is favorable, with net inflows of $27.79 billion. This is among the highest net inflows seen over the last one-year and the rate of additional inflows appears to be increasing. Economic sentimentPMI by IHS Markit | PositiveAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is strong relative to the trend shown over the past year, and is accelerating. Credit worthinessCredit default swap | NegativeThe current level displays a negative indicator. DGX credit default swap spreads are near their highest levels of the last 3 years, which indicates the market's more negative perception of the company's credit worthiness.Please send all inquiries related to the report to email@example.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
Most investors tend to think that hedge funds and other asset managers are worthless, as they cannot beat even simple index fund portfolios. In fact, most people expect hedge funds to compete with and outperform the bull market that we have witnessed in recent years. However, hedge funds are generally partially hedged and aim at […]
A replay of the call may be accessed online at www.QuestDiagnostics.com/investor or by phone at 866-480-3547 for domestic callers or 203-369-1551 for international callers, no passcode is required. Telephone replays will be available from approximately 10:30 a.m. Eastern Time on April 23, 2019 until midnight Eastern Time on May 7, 2019. Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management.
Want to participate in a research study? Help shape the future of investing tools and earn a $60 gift card! This article is for investors who would like to improve their understanding of price to earnings ratios (P/E ratios). We...
SECAUCUS, N.J. , April 3, 2019 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today awarded Supplier Excellence awards to four companies ...
Rosenblatt Securities initiated Disney as buy Deutsche Bank initiated Dow Inc. as buy Deutsche Bank initiated Intuitive Surgical as buy Jefferies upgraded Lab Corp to buy from hold Jefferies upgraded Quest Diagnostics to buy from hold Deutsche Bank upgraded Hostess Brands to buy from holdHere are the biggest calls on Wall Street on Tuesday: Rosenblatt Securities initiated Disney as 'buy'Rosenblatt is bullish on Disney DIS 's direct-to-consumer strategy.
SECAUCUS, N.J. , April 1, 2019 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, received a perfect score of 100 from the Human ...
GuideStone Capital Management President David Spika joins Yahoo Finance's Adam Shapiro, Julie Hyman, Jared Blikre, and MIT Professor Sinan Aral.